19//10//11
MediWiSe make it three at QMB
London's leading bio-innovation centre gains its third tenant this year
Press Release 20th October 2011
QMB Innovation Centre
(“QMB” or “the Innovation Centre”)
MediWiSe make it three at QMB
London’s leading bio-innovation centre gains its third tenant this year
Queen Mary BioEnterprises (QMB) Innovation Centre, London’s newest high-specification incubator facilities for start-up and early stage life science businesses, is pleased to announce Medical Wireless Sensing Ltd (“MediWiSe”), an innovative medical devices company specialising in the applied Science of Metamaterials, has signed a lease to become QMB’s third tenant.
MediWiSe designs, develops and tests innovative medical devices based on Microwave Medical Imaging (MMI) technology for non-invasive, early-stage screening of cancer. MediWiSe’s expertise is at the forefront of new technological developments and is aiming to become a leader in the new generation of medical imaging. The Company’s initial focus is in breast cancer.
Simone Reid, Business Development Director of QMB commented: “I am delighted that MediWiSe has chosen QMB Innovation Centre as a permanent base as it looks to push the company forward and continue its evolution. It is an interesting and innovative company and complements our existing tenants.”
George Palikaras, Founder and CEO of MediWiSe, said: “The QMB Innovation Centre has already become a vital ally. They have provided strategic guidance, access to investors, mentors, a ready-made network of contacts, specialised training, affordable space, and professional services at reduced rates. We are confident that being inside the QMB Innovation Centre will help us achieve our aims.”
Simone Reid continued: “MediWiSe’s addition to QMB now means we have added three tenants and let over 15,000 square feet of space since February 2011. We are incredibly pleased with this level of take up and feel it justifies and strengthens our belief that QMB can become a premier bio-hub in the UK.”
-Ends-
For further information
Media Enquiries
Notes to Editors
About Queen Mary Bioenterprises Limited (“QMB” or “the Innovation Centre”)
The QMB Innovation Centre provides state of the art, customisable laboratory and office space within minutes of The City of London.
QMB provides business incubation support for new ventures and aims to become a hub for science and technology entrepreneurs in London. It provides all its clients with access to the wide range of professional services required when spinning a company out of academia and supports them through the critical phases of their development. The Innovation Centre’s proximity to the City of London means that it is well placed for clients to meet with the UK investment community and other advisers.
The 39,000 square foot facility comprises three floors of high specification work space for start up science and technology businesses. Lab designs are based on varied write up / laboratory split, and have been designed with a sophisticated air filtration system to house both microbiological safety cabinets and chemistry fume cupboards. This makes QMB an ideal location for both very early stage start ups as well as more established companies looking to expand. The Innovation Centre has a 120 seat lecture theatre and regularly hosts seminars and conferences which aim to promote the growth of the biotechnology industry in the UK.
QMB’s keystone tenant is Retroscreen Virology Ltd, a virology contract research organisation, whose bespoke facilities in the Innovation Centre include laboratory space and capacity to run clinical trials. QMB has recently signed its second tenant, iGene which will be housed on the first floor. The QMB Innovation Centre has 39,000 square feet of building capacity.
The QMB Innovation Centre is a wholly owned company of Queen Mary, University of London. It is the culmination of a four-year capital investment partnership between Queen Mary and the London Development Agency.